{
    "2019-09-12": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Puma Biotech's sNDA for Nerlynx Combo Gets FDA Acceptance",
                "features": {
                    "keywords": [
                        "Puma",
                        "Biotech",
                        "sNDA",
                        "Nerlynx",
                        "FDA",
                        "Acceptance"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "J&J's Ponesimod Superior to Aubagio in Relapsing MS Patients",
                "features": {
                    "keywords": [
                        "J&J",
                        "Ponesimod",
                        "Aubagio",
                        "Relapsing",
                        "MS",
                        "Patients"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Has Novartis (NVS) Outpaced Other Medical Stocks This Year?",
                "features": {
                    "keywords": [
                        "Novartis",
                        "NVS",
                        "Medical",
                        "Stocks",
                        "Outpaced"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}